key: cord-0010461-pswko1pa
authors: AUTHEMENT, JENNIFER M.
title: Preparation of Components
date: 2012-11-07
journal: Adv Vet Med
DOI: 10.1016/b978-0-12-039236-0.50011-4
sha: bf75920a402c68000f62adb971ebb59da50a203a
doc_id: 10461
cord_uid: pswko1pa

nan

Canine blood donors should be in good physical condition, have a calm disposition, have no history of previous transfusions, and be greater than 50 pounds in body weight. Greyhounds are used as blood donors because they have a high packed cell volume (normally over 60%), easily accessible venipuncture sites, a docile disposition, and a low frequency of DEA-1.1, DEA-1.2, and DEA-7 antigens (Greene, 1980) . Dogs are considered "universal donors" if they are negative for both DEA-1 loci. Table I lists the canine blood groups and their frequency of occurrence. (See also Smith, this volume, for the gene frequency of each group.)

Feline blood donors should be in good physical condition, easy to handle, have no history of previous transfusions, and they should weigh Pichler and Turnwald (1985) . Re printed with permission. more than 8 pounds. Cats have three blood types: A, B, and AB. They are not routinely blood typed because the reagents are not readily available and there is a low frequency of type B cats in the United States (Giger et al., 1989) . Those cats with type B blood have naturally occurring isoantibodies that can result in serious incompatibility reac tions if transfused with type A blood. (See Smith, this volume; Cotter, this volume ["Clinical Transfusion Medicine"] .) Blood typing is avail able at several veterinary schools. In a situation requiring an immedi ate transfusion, a major cross match may be done to detect incompati bility reactions

Routine health maintenance of canine blood donors should include current vaccinations for distemper, hepatitis, leptospirosis, parainfluenza, parvovirus, and rabies. Feline donors should be vaccinated for feline viral rhinotracheitis, calicivirus, panleukopenia, and rabies. Ide ally, feline donors should be confined to decrease exposure to feline immunodeficiency virus and feline leukemia virus as well as to other infectious diseases. Vaccinations should be not given to all donors at once because modified-live virus vaccinations can alter platelet and endothelial function for up to 10 days postvaccination (Dodds, 1978; Authement et al., 1987) .

Canine blood donors should be heartworm negative and be receiving preventative medication in endemic areas. Both canine and feline donors should have periodic physical examinations and have a yearly complete blood count, chemistry profile, urinalysis (optional), and fecal examination. Titers to infectious agents including Ehrlichia canis, Ehrlichia platys, Babesia canis, Hemobartonella canis, and Trypanosoma cruzi should be monitored for canine donors depending on local prevalence (Pichler and Turnwald, 1985; Authement et al., 1987) . Feline donors should be monitored yearly for feline leukemia and feline immunodeficiency virus (Cotter, 1988) . Feline infectious peritonitis (FIP) titers are cross-reactive with other coronaviruses and do not necessarily reflect a carrier state. For these reasons routine testing of healthy donors may not be warranted.

Donors should be fed a balanced diet with adequate vitamins, minerals, and protein. Oral iron can be supplemented at 0.5 mg iron/ml of blood taken for donors that are used on a monthly basis (Cotter, 1988) . There is controversy as to whether donors should be splenectomized so that red blood cell parasites are easier to detect. The author thinks that this is not necessary. Splenectomized dogs may have an increased risk of becoming infected with H. canis, B. canis, and other organisms because of decreased reticuloendothelial function.

Adult horses and cattle can safely donate four liters of blood at a time. They should test negative for retroviruses (equine infectious anemia and bovine leukemia virus).

Because of the ethical and economic concerns of confining an animal for the purpose of blood donation, outpatient donor programs can be established. Pet owners and employees willing to become participants in a small animal blood bank should be questioned regarding the health of their pet, the frequency of donation that may be required, and the form of compensation (if any) they require. Most owners are satisfied to allow their pet to donate every 1 to 2 months in exchange for a yearly physical examination, vaccinations, blood, and heartworm tests. Outpatient donors should meet the same size, health, and testing requirements described previously. Parasite control is essential for outpatient donors, especially for canine donors that live in areas where heartworm and tick-transmitted rickettsial diseases are prevalent.

FIG. 1. Triple-beam balance scale used to monitor volume of blood being drawn and to balance bags for centrifugation. From Authement et al. (1987) . Reprinted with permission.

The most popular site from which blood can be collected from canine, feline, and equine donors is the jugular vein. In anesthetized animals, blood can be collected from the femoral artery, carotid artery, or via direct cardiac puncture prior to euthanasia. Feline donors are generally sedated with 0.5 mg midazolam, 5 mg ketamine, and 0.2 mg atropine given intravenously (Cotter, 1988) . The area around the jugular vein should be clipped and surgically prepared. A hemostat should be placed on the plastic tubing connecting the needle to the collection bag to prevent air from entering the line. The hemostat is removed once the vein has been entered. Venipuncture should be clean with rapid flow of blood to minimize the activation of platelets and coagulation factors as well as tissue thromboplastin contamination. Dogs over 25 kg may donate 450 ml (maximum 20 ml/kg) and cats over 5 kg may donate 50 ml as often as every 2 weeks. If feline donors show signs of hypovolemia, such as pale mucous membranes, prolonged capillary refill time, tachycardia, or decreased pulse intensity, 100 ml of Ringer's lactate solution or saline should be given intravenously (Cotter, 1988) . Direct pressure should be applied over the venipuncture site once the appropriate volume of blood is collected and the needle removed. A scale should be used to measure the amount of blood being drawn (Fig. 1) . A CPDAi bag should be selected with the correct number of satellite bags needed for component preparation. One satellite bag (termed a double bag) is needed for a fresh-frozen plasma and platelet-rich plasma preparation; two satellite bags (termed a triple bag) are needed for platelet concentrate or cryoprecipitate preparation (Fig. 2) . During collection FIG. 4 . Balanced units are placed in centrifuge so seams are not in direction of the centrifugal force. From Authement et al. (1987) . Reprinted with permission. the blood should be mixed with the anticoagulant by gently rocking the bag.

A standard blood collection bag contains enough anticoagulant for 450 ml ± 10% of blood. If a smaller volume of blood is needed the appropriate amount of anticoagulant should be expressed out of the bag to avoid citrate toxicity in the recipient. The ratio of citrate to blood volume collected should be approximately 1:7. For cats, all of the CPDAi can be expressed into the satellite bag, leaving the 8 ml remaining in the tubing as anticoagulant for 50 ml of whole blood (Cotter, 1988) .

Following collection of the desired blood volume, the tube is tied or clamped near the needle, which is removed from the collection line. Blood left in the tube is "stripped" with a tube stripper 1 into the bag two 1 Tube Stripper (4R4415) Fenwal, Division of Travenol Laboratories, Inc., Deerfield, IL 60015. From Authement et al. (1987) . Reprinted with permission.) to three times to allow mixing of the blood with the anticoagulant in the bag and return of the citrated blood to the tube (Fig. 3A) . The segment along the tube can then be tied off, clamped with hand sealer clips 2 (Fig.  3B ), or heat sealed 3 (Fig. 3C ) at sites along the tube designated by an "x." The segments can be used for performing cross matches. A segment should remain with a bag for purposes of identification (Authement et aL, 1987) . The unit of blood should be labeled with the donor's name, blood type, species, date collected, date of expiration, and component type.

Blood collected in CPDAi bags should be refrigerated at 1-6°C until centrifugation except when platelets are needed. Platelet function is better maintained when platelets are stored at room temperature. For preparation of fresh-frozen plasma (FFP), bags should be balanced by weight and centrifuged in a refrigerated centrifuge at a speed (rpm) to achieve 5000 g for 5 minutes. Rubber bands, gauze, and other soft items can be used to balance the bags. The CPDAi bags should be placed so that the seams of the bags are not in the direction of the direct centrifugal force (Fig. 4) .

Following centrifugation the plasma is expressed into the appropriate satellite bag with a plasma extractor 4 (Fig. 5) . If a triple bag (two satellites) is being used to make cryoprecipitate or platelet concentrate, one satellite should be closed off temporarily with a clamp, paper clip, or similar device. Plasma is allowed to flow into the satellite bag, avoiding Authement et al. (1987) . Reprinted with permission. contamination with red cells. A small amount of plasma may be left with the packed red cells so that the packed cell volume (PC V) of the packed red cells is approximately 80%. The plasma tube can be segmented by heat or tube sealer clips for use in a minor cross match if desired. The red cells should be labeled as packed red cells, stored at 1-6°C, and mixed periodically to distribute ATP, glucose and 2,3-DPG within the bag (Tangner, 1982) . The remaining plasma can be frozen at -20 to -30°C as FFP if separated and frozen within 6 hours of collection. The FFP can be stored for 1 year with adequate maintenance of clotting factors (Widmann, 1985) . If the plasma is separated greater than 6 hours after collection, or stored for longer than 1 year, it is labeled as frozen plasma (FP), which has decreased levels of clotting factors but can be kept for an additional 4 years to treat factor IX deficiency and warfarin toxicity, or used as a source of albumin (Widmann, 1985) . Plasma units should be frozen in boxes boxes the plastic becomes fragile when frozen and may crack with manipulation.

For platelet-rich plasma (PRP) preparation, whole blood should be centrifuged at room temperature at 2000 g for 3 minutes, and the PRP expressed into a satellite bag until the red cell layer is reached (J. Wardrop, personal communication, 1990 ). This will provide a yield of at least 5.5 x 10 10 platelets/unit. For platelet concentrate preparation, the PRP is centrifuged at 4000 g for 6 minutes, resulting in a "platelet plug" at the bottom of the satellite bag. Platelet-poor plasma is expressed into the second satellite and can be used as FFP, leaving 50-70 ml of plasma with the platelet concentrate. The concentrate is then allowed to rest undisturbed for 60-90 minutes and the platelets are then gently resuspended and infused with a Fenwal 4C223 component administration set. Ideally, PRP and platelet concentrate should be administered as soon as possible. If they have to be stored, they can be kept on a rocker and mixed frequently at room temperature for 72 hours after collection (Widmann, 1985) . DEA-1-negative dogs receiving repeated platelet transfusions should received platelets from DEA-1-negative donors to avoid sensitization. Sensitization to histocompatability antigens occurs quickly, resulting in rapid removal of platelets (Slichter et al., 1988 ; See also Cotter, this volume ["Clinical Transfusion Medicine"]).

For cryoprecipitate preparation, FFP can be stored for up to 12 months at -30°C prior to the harvesting of cryoprecipitate, but the expiration date for the cryoprecipitate is 1 year from the date the blood was drawn (Widmann, 1985) . The FFP is thawed slowly at 1-6°C in a refrigerator for 5-7 hours to a slushy consistency. The partially frozen plasma is then centrifuged at 4°C and 5000 g for 5 minutes and the plasma is expressed into a second satellite bag. J. Wardrop (personal communication, 1990 ) recommends hanging the bag in an inverted position and allowing the supernatant plasma to drain into the satellite. The white precipitate (cryoprecipitate) remaining in the first satellite bag along with 10-15 ml of plasma should be frozen immediately at -30°C in a box. The remaining "cryopoor plasma" can be used as a source of albumin or vitamin K-dependent stable coagulation factors.

In large animal patients the blood component that has the greatest use is plasma. The most important application of plasma in large animals is in the treatment of failure of passive transfer in neonatal animals and in treating diseases that cause hypoproteinemia (Morris, 1987) . Foals and calves that fail to ingest adequate colostrum for acquisition of passive immunity during the first 24 hours of age require an intravenous source of serum immunoglogulin. Plasma should be prepared from animals that are negative for erythrocyte alloantibodies. Foals with a serum IgG less than 8 g/liter and calves with a serum IgG less than 20 g/liter are at risk for infections (Morris, 1987) . (See Paradis, this volume for further discussion.) Plasma transfusions have also been given to treat hypoproteinemia secondary to protein-losing enteropathy from salmonellosis, inflammatory bowel disease, or other diseases of the gastrointestinal tract (Morris, 1987) . Very large volumes are required to raise albumin levels.

Because horses have a rapid erythrocyte sedimentation rate, plasma can be collected from blood that has been collected in bottles containing anticoagulant and allowed to stand for 1-2 hours. Disadvantages of this procedure are sepsis secondary to bacterial contamination and sensitization of the recipient to excess numbers of red blood cells. Because the system is not closed, the plasma should be given immediately after separation.

If whole blood is to be collected for future administration of red blood cells, the donor horse should be A/Q negative and should not have been previously transfused. Whole blood can be collected into liter bags containing ACD solution (1:7 dilution of anticoagulant in whole blood). Appropriate amounts of anticoagulant can be transferred into a 2-or 4-liter blood collection bag 5 ' 6 in an aseptic manner. The donor should have the venipuncture site surgically prepped. A large-bore catheter (10-12 gauge) should be used in this procedure. A two-lead collection set 7 can be used and one branch of the Y-set leading to the citrate filled bag should be clamped. Blood is allowed to flow into the collection bag by gravity flow and the bag is gently rocked to ensure adequate mixing with anticoagulant. When the bag is filled, the clamp can be closed and another bag filled using a second lead. A 2-liter bag should weigh 1800 grams and a 4-liter bag should weigh 3600 grams when filled with blood. Plasma can be separated into a plasma transfer bag with a plasma extractor following sedimentation of the red cells.

Blood should be collected in an aseptic manner, separated in a closed system, and stored under restricted conditions to maintain the viability and function of each constituent, to prevent detrimental physical changes and to minimize bacterial proliferation.

In veterinary medicine the most common anticoagulants used for the collection and preservation of blood and its components are citratephosphate-dextrose-adenine (CPDAi) and acid-citrate-dextrose (ACD). Citrate binds calcium to inhibit the calcium-dependent steps in the coagulation cascade. Phosphate contributes to the formation of ATP and dextrose is an energy source for red blood cells. CPDAi is the preferred anticoagulant because 2,3-DPG and ATP levels are better maintained. It has been reported that canine blood can be stored for 35 days in CPDAi; however, a recent study showed that the posttransfusion viability of canine packed red cells stored for 30 days in CPDAi was 73% (Price et al., 1988) . This study concluded that canine red cells preserved in CPDAi should not be stored for greater than 20 days, though additional studies need to be done. The Food and Drug Administration requires 75% red cell survival posttransfusion as a minimum standard for human transfusions.

Heparin is an anticoagulant with no preservative function, so heparinized blood preferably should be used with 8 hours (Widmann, 1985) . If blood is to be collected in heparin, 250 units (1000 units/ml) diluted in 3-4 ml of saline can be placed in a syringe before blood is drawn into that syringe. Heparin is not recommended for patients with coagulopathies because of its longer duration of anticoagulant activity, whereas citrate is metabolized within minutes.

Containers that can be used to collect blood are glass vacuum bottles, plastic bags, and plastic syringes. Blood should be stored only in glass bottles or plastic bags because these are considered closed systems. Plastic bags and glass bottles are compared in Table II . The major advantage of plastic bags is that they enable plasma to be separated from red cells within a closed system and maintain platelet function. Collection of blood in bottles is faster because of the vacuum; however, this vacuum may damage erythrocytes during collection (Pichler and Turnwald, 1985) .

Changes that occur during blood storage at 1-6°C are a decrease in pH, 2,3-DPG, and ATP and an increase in ammonia (Authement et al., Activation of platelets Activation of factor XII Breakable and more expensive More storage space required More potential for bacterial contamination Separation of blood components is more difficult 1987). The pH decreases when red blood cells metabolize glucose to lactate, resulting in hydrogen ion accumulation. Patients most affected by the decrease in 2,3-DPG are those receiving massive transfusions because of hemorrhage or hemolysis. High levels of 2,3-DPG promote release of oxygen to peripheral tissues by decreasing the affinity of hemoglobin for oxygen. It generally takes 24 hours to complete regeneration of 2,3-DPG once stored blood is transfused. Citrate in the anticoagulant binds calcium, resulting in decreased concentrations of ionized calcium. Clinical signs can occur in patients transfused rapidly with large volumes of citrated whole blood or plasma, or in patients with hepatic insufficiency in which citrate metabolism is impaired (Authement et al., 1987) .

The increase in blood ammonia is primarily a complication when stored blood is given to patients with hepatic disease and hepatoencephalopathy.

The electrolyte abnormalities that occur in human stored blood (increased plasma potassium and decreased plasma sodium) do not occur in canine erythrocytes because the red cell potassium level is not as high as that in humans (Greene, 1980) . Hyperkalemia can occur in stored equine blood. As the erythrocyte ages it loses intracellular and membrane water, glucose, ATP, protein, and lipid, resulting in a spherical shape. Spherical erythrocytes are not capable of deforming and moving through the capillaries and as a result they are removed by the reticuloendothelial system, especially the spleen. This aging process corresponds to changes that occur in stored blood. Some of the morphologic and functional changes are reversible posttransfusion.

Hemapheresis is the removal of whole blood from a donor or patient, separation into components with retention of the desired component, and return of the remaining components to the donor or patient (Widmann, 1985) . The desired component can be removed for use in the transfusion of a recipient or a pathologic component can be removed as therapy for a disease process. Cytapheresis is the collection of cells, primarily platelets and granulocytes. Plasmapheresis is the removal of plasma from the donor or patient and subsequent return of the red blood cells with a replacement solution such as saline or colloid. Examples of conditions in which hemapheresis can be used in veterinary medicine include removal of autoantibody or paraprotein or to decrease the hematocrit in patients with polycythemia vera (Klausner et al., 1986) .

Most apheresis machines use centrifugal forces and the different densities of the various blood components to achieve the separation of the desired fraction. Filtration methods are available for selective removal of components or substances by perfusion of plasma constituents. A manual method of plasmapheresis requires blood donation by the patient, centrifugation of the whole blood with expression of plasma into the satellite bag, and returning red blood cells diluted in saline to the recipient. Hemapheresis generally requires expensive technology, professional supervision, and a significant amount of donor time, limiting its application in veterinary medicine to academic settings.

Canine blood component therapy: Product preparation, storage, and administration

Blood banking. I. Collection and storage; Blood banking. II. Indications and side effects

Management and therapy of bleeding disorders. Bi-Wkly

Frequencies of feline blood groups in the United States

Practical considerations in blood transfusion therapy

Therapeutic hemapheresis

Blood products in large animal medicine. A comparative account of current and future technology

Blood transfusion in the dog and cat. Part 1. Physiology, collection, storage, and indications for whole blood therapy

Evaluation of citrate-phosphate -dextrose-adenine as a storage medium for packed erythrocytes

Approaches to preventing or reversing platelet alloimmunization using animal models

Transfusion therapy for the dog and cat

AABB Technical Manual